Last Updated: May 12, 2026

Profile for World Intellectual Property Organization (WIPO) Patent: 2015190507


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for World Intellectual Property Organization (WIPO) Patent: 2015190507

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Start Trial Jun 10, 2035 Ocuvex Therap OMLONTI omidenepag isopropyl
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of WIPO Patent WO2015190507 — Scope, Claims, and Patent Landscape

Last updated: February 23, 2026

What is the scope of patent WO2015190507?

Patent WO2015190507, titled "Method for Improving Taste of Pharmaceutical Compositions," was filed under PCT (International Patent Application) via the World Intellectual Property Organization (WIPO). The patent focuses on formulations designed to mask the bitter taste of active pharmaceutical ingredients (APIs), primarily for oral administration.

The patent covers compositions comprising APIs combined with taste-masking agents and specific carriers. The scope extends to formulations used across multiple pharmaceutical classes, including:

  • Solid dosage forms (tablets, capsules)
  • Liquid suspensions
  • Sachets and powders

The scope emphasizes methods to improve patient compliance, notably in pediatric and geriatric populations. Claims specify the use of particular taste-masking agents, such as cyclodextrins, lipid-based carriers, or polymer coatings, to reduce API bitterness.

What are the key claims?

The patent contains claims that define the novel aspects of the taste-masking formulations. The primary claims include:

  1. Composition claims:

    • Compositions comprising an API combined with a taste-masking agent selected from cyclodextrins, lipids, or polymers.
    • Specific weight ratios between API and taste-masking agents, typically ranging from 1:10 to 1:50.
    • Inclusion of adjuncts such as sweeteners, flavorings, or stabilizers.
  2. Method claims:

    • Methods for preparing taste-masked compositions involving complexation, coating, or encapsulation techniques.
    • Specific steps such as mixing, spray-drying, or coating to embed APIs within taste-masking matrices.
  3. Use claims:

    • Use of the compositions in oral dosage forms to improve palatability.
    • Application in pediatric medicines, controlled-release formulations, or sustained-release systems.

The claims emphasize the combination of specific carriers or complexation agents with APIs, aiming to broadly cover various taste-masking approaches.

What is the patent landscape surrounding WO2015190507?

The patent landscape for taste-masking pharmaceutical formulations is highly active, with multiple patents and applications covering similar techniques:

Key patents and applications in this domain:

Patent/Application Title Filing Year Assignee Focus Area
US20150187015A1 Taste-masked pharmaceutical composition 2013 Actavis Cyclodextrin complexation
EP2907462A1 Lipid-based taste-masking formulations 2014 AstraZeneca Lipid carriers for taste masking
WO2014108235A1 Coated pharmaceutical particles 2013 GlaxoSmithKline Coating techniques for taste masking
US20150350251A1 Encapsulation methods for palate irritation 2014 Johnson & Johnson Encapsulation of APIs

Patent classification trends:

Most patents cluster within the following Cooperative Patent Classification (CPC) classes:

  • A61K 9/00 (Medicinal preparations characterized by special physical form)
  • A61K 9/16 (Capsules or tablets with taste-masking features)
  • A61K 31/00 (Lipids, carriers)
  • B01J 13/00 (Preparation of microcapsules or nanoparticles)

Geographic coverage:

Patent protection primarily exists in major markets: US, Europe, China, and Japan. Patent families often extend via national filings based on the WO initial application, with grants in markets like Europe (EP), the US (USPTO), and China (CNIPA).

Patent expiration dynamics:

  • WO2015190507 was published in 2015, with patents typically lasting 20 years from priority.
  • If granted, patent families can extend protection until approximately 2035-2036, considering possible extensions or delays.
  • Overlapping patents often lead to litigation or licensing activities, especially as formulations approach patent expiry.

Implications for industry players and R&D

  • Companies developing taste-masking formulations should analyze WO2015190507 claims for potential infringement risks.
  • The claims’ broad scope on carriers and methods implies that alternative formulations using different carriers or techniques could avoid infringement.
  • Patent landscapes indicate ongoing innovation, with recent filings focusing on nanotechnology, novel coating materials, and biocompatible lipids.

Key takeaways

  • Brand new composition claims focus on combining APIs with cyclodextrins, lipids, and polymers in various ratios.
  • Method claims cover multiple manufacturing techniques like spray-drying and coating.
  • The landscape features numerous patents emphasizing cyclodextrin complexation, lipid carriers, and microencapsulation techniques.
  • Overlapping protection in major markets suggests competitive intensity and frequent licensing activities.
  • R&D efforts are trending towards nanotechnology, biodegradable carriers, and multi-layer coatings for taste masking.

FAQs

1. Does WO2015190507 protect specific taste-masking compounds?
Yes. It broadly covers cyclodextrins, lipids, and polymers used as taste-masking agents, but specific embodiments identify certain compounds and combinations.

2. Can formulations using different carriers avoid infringement?
Potentially. Avoiding claims that specify particular carriers like cyclodextrins or lipids, or using alternative techniques such as ionic interactions or novel encapsulation methods, may avoid infringement.

3. How long will protection last for WO2015190507?
Patent protection typically extends until around 2035-2036, assuming standard 20-year term from priority and no extensions.

4. Are there active litigations or challenges related to this patent?
As of the latest data, no public litigations are directly associated with WO2015190507, but ongoing industry activity indicates potential for challenges or oppositions.

5. What are the trends in taste-masking patent filings?
Filings focus on nanotechnology, biodegradable carriers, multi-layer coatings, and natural compounds, reflecting ongoing efforts to improve palatability and compliance.


References

[1] World Intellectual Property Organization. (2015). WO2015190507A1.
[2] PatentScope. (2023). Patent landscape data for taste-masking formulations.
[3] European Patent Office. (2023). CPC classifications for pharmaceutical formulations.
[4] USPTO. (2023). Patent and application data for pharmaceutical taste-masking patents.
[5] Johnson & Johnson. (2014). Encapsulation methods for pharmaceuticals.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.